PrateekDharWaliMD
Pediatric Gastroenterology • Little Rock, ARPediatric Inflammatory Bowel Disease Gastroenterology
Prateek D. Wali, MD Vice Chair for Clincal Strategy Arkansas Children’s Hospital Pediatric Gastroenterology, Hepatology and Nutrition University of Arkansas for Medical Sciences
Dr. Wali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Children’s Way
Little Rock, AR 72202Phone+1 501-364-1901
Summary
- Prateek Wali MD, specializes in Pediatric Gastroenterology and is based in Little Rock, AR. He completed his education at SUNY Upstate Medical University in 2004, including his residency completed in 2007. He completed his fellowship in Pediatric Gastroenterology in 2010 from Nemours A.I. DuPont Hospital for Children. From 2010-24, he has served as director of the pediatric inflammatory bowel disease program and an attending physician at SUNY Upstate Golisano Children’s Hospital. Dr. Wali has authored publications focusing on pediatric inflammatory bowel disease. In addition, he served as division chief of pediatric gastroenterology at SUNY Upstate Golisano Children’s Hospital from 2017-24. Currently he is Vice Chair for Clinical Strategy at Arkansas Children’s Hospital.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonFellowship, Pediatric Gastroenterology, 2007 - 2010
SUNY Upstate Medical UniversityResidency, Pediatrics, 2004 - 2007
SUNY Upstate Medical UniversityClass of 2004
Syracuse UniversityBS, Biology/psychology , 1996 - 2000
Certifications & Licensure
AR State Medical License 2024 - 2025
NY State Medical License 2010 - 2025
DE State Medical License 2009 - 2011
PA State Medical License 2008 - 2010- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Clinical Trials
- Predicting Response to Standardized Pediatric Colitis Therapy Start of enrollment: 2012 Jul 10
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Start of enrollment: 2022 Apr 30
Roles: Principal Investigator
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Start of enrollment: 2022 Apr 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease.Jeremy Adler, Joseph A Galanko, Rana Ammoury, Keith J Benkov, Athos Bousvaros
The American Journal of Gastroenterology. 2024-10-18 - Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.Jonathan Moses, Jeremy Adler, Shehzad A Saeed, Ann M Firestine, Joseph A Galanko
Inflammatory Bowel Diseases. 2024-10-17 - 3 citationsHigh Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease.Dawn R Ebach, Traci W Jester, Joseph A Galanko, Ann M Firestine, Rana Ammoury
The American Journal of Gastroenterology. 2024-06-01
Press Mentions
- Can Proper Nutrition Affect Autism Behaviors? Experts Weigh InApril 4th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
